Zimmer Biomet (NYSE:ZBH) said yesterday it tapped former Covidien investor relations head Coleman Lannum as its investor relations senior VP, reporting directly to prez & CEO Bryan Hanson. Lannum has more than 15 years in investor relations, having held positions with Mallinckrodt Pharmaceuticals (NYSE:MNK), Covidien and Tyco Healthcare. During his time with Covidien, Lannum oversaw the company’s initial […]
The United States Department of Defense awarded nearly $1.1 billion worth of contracts to 3 medical device firms.
UPDATED March 29, 2013, with comment from Covidien.
Richard Meelia, the CEO who led Covidien plc (NYSE:COV) in its various incarnations for more than two decades will hand over the keys to the corner officer to José (Joe) Almeida today without fanfare.
Meelia, 62, was named president & CEO of Covidien in June 2007, after it was spun out of the disintegrating Tyco International. He was elected chairman in October 2008 and has been with the company in its different forms for 20 years.
A group of at least 57 product liability lawsuits filed against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics over one of its metal-on-metal hip implants were consolidated in the U.S. District Court for Northern Texas.
Tyco Healthcare, the corporate ancestor of Covidien plc (NYSE:COV), agreed to pay $32.5 million to settle a class-action antitrust lawsuit filed by a Louisiana hospital and a drug company accusing it of seeking to monopolize the market for the disposal of needles and syringes.
The Natchitoches Parish Hospital Service District and Smith Drug Co. sued Tyco in the U.S. District Court for Massachusetts, accusing Tyco of entering into exclusive purchasing contracts for sharps containers with individual customers and group purchasing organizations. Under the terms of the latter deals, the GPOs allegedly agreed not to broker sharps container sales by Tyco’s competitors.